Abiopharma

🔍 Mei Lily (Executive)

Company: Velo3D, Inc. (VELO)

Report Date: 2026-06-12

Detailed Transactions and Holdings:

• Acquired 7,843 shares of Restricted Stock Unit (Derivative)
  Date: 2026-06-12 | Code: A | equity_swap_involved: false | shares_owned_after: 7,843.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Velo3D, Inc. (the "Company"), granted under the Company's 2021 Equity Incentive Plan. The Compensation Committee (the "Committee") of the Board of Directors of the Company, in its sole discretion, may settle earned RSUs in cash, shares of common stock of the Company, or a combination of both.
• F2: Initial RSU award after joining the Board, which vests on the first anniversary of the grant date, provided such director continues to serve as a director through the vesting date.